Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

300357 Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.

Closed 10-16 15:00:00

18.87

-0.08

-0.42%

High19.56	Low18.69	Vol5.95M
Open19.15	D1 Closing18.95	Amplitude4.59%
Mkt Cap9.89B	Tradable Cap9.15B	Total Shares524.00M
T/O114.00M	T/O Rate1.23%	Tradable Shares485.00M
P/B3.6	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"300357","market":"SZ","secType":"STK","nameCN":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.","latestPrice":18.87,"timestamp":1792134198000,"preClose":18.95,"halted":0,"volume":5954437,"delay":0,"changeRate":-0.0042,"floatShares":484999999,"shares":524000000,"eps":0.7972,"marketStatus":"Closed","change":-0.08,"latestTime":"10-16 15:00:00","open":19.15,"high":19.56,"low":18.69,"amount":114000000,"amplitude":0.0459,"askPrice":18.87,"askSize":77,"bidPrice":18.86,"bidSize":90,"shortable":0,"etf":0,"ttmEps":0.7972,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":18.95,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":20.85,"lowLimit":17.06,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":523584000,"isCdr":false,"pbRate":3.6,"roa":"--","peRate":23.670346,"roe":"7.87%","epsLYR":0.7276,"committee":-0.013283,"marketValue":9880000000,"turnoverRate":0.0123,"status":1,"floatMarketCap":9160000000},"requestUrl":"/m/hq/s/300357/wiki","defaultTab":"wiki","newsList":[{"id":"1127340518","title":"Wolwo Bio-Pharmaceutical's Subsidiary Wins Clinical Trial Approval for Human Umbilical Cord Mesenchymal Stem Cell Type II Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1127340518","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127340518?lang=en_us&edition=fundamental","pubTime":"2026-10-11 17:04","pubTimestamp":1791709453,"startTime":"0","endTime":"0","summary":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (300357.SZ) has announced that its indirectly controlled subsidiary, Zhejiang Wolwo Stem Cell Technology Co., Ltd. (hereinafter referred to as \"Zhejiang...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","MDTX","300357","IBBJ","PSYK","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104245937","title":"Wolwo Bio-Pharma Founder Steps Down Following Divorce, Ex-Wife Takes Control as Sole Actual Controller","url":"https://stock-news.laohu8.com/highlight/detail?id=1104245937","media":"Deep News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104245937?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:51","pubTimestamp":1788965474,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (300357.SZ) have drawn market attention after the company announced a leadership transition tied to the personal affairs of its founder. Chairman...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","300357","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118732760","title":"A-share Market Witnesses Another Billion-Yuan Divorce Settlement as Founder Departs and Ex-Wife Takes Control","url":"https://stock-news.laohu8.com/highlight/detail?id=1118732760","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118732760?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:20","pubTimestamp":1788952843,"startTime":"0","endTime":"0","summary":"China's A-share market has seen yet another high-value divorce settlement, with the founder of Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (300357.SZ) and his wife finalizing the division of 5.4...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02827","02846","BK0028","03130","BK0239","82846","03188","399300","300357","83188","BK1147","83130","07233","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666586286","title":"Zhejiang Wolwo Bio's Controlling Shareholder Pledges 35 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666586286","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666586286?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:57","pubTimestamp":1788944238,"startTime":"0","endTime":"0","summary":"Zhejiang Wolwo Bio-Pharmaceutical  said its controlling shareholder, Zhejiang Wolwo Management Consulting, pledged 35 million shares in the company to Guotai Haitong Securities on Monday, according to a Tuesday filing.The pledged shares represent 17% of the shareholder's stake, and 6.68% of the company's total shares.Following the transaction, Zhejiang Wolwo Management Consulting holds 203.5 million shares, or 39% of the company, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0028","300357"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161928107","title":"Shift in Ownership: Zhejiang Wolwo Bio-Pharmaceutical's Controller Changes Following Divorce Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=1161928107","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161928107?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873264,"startTime":"0","endTime":"0","summary":"The controlling shareholder structure of Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. has been altered following a marital separation involving its top executives.On the evening of September 8, the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","IPOS","300357","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322241","title":"Zhejiang Wolwo Bio-Pharmaceutical Says Chairman Hu Gengxi Resigned Due to Personal Reason","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322241","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322241?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:12","pubTimestamp":1788865934,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0028","BK0239","300357"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322223","title":"Zhejiang Wolwo Bio-Pharmaceutical's Chairman Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322223","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322223?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:12","pubTimestamp":1788865934,"startTime":"0","endTime":"0","summary":"BRIEF-Zhejiang Wolwo Bio-Pharmaceutical's Chairman ResignsSept 8 (Reuters)-Zhejiang Wolwo Bio-Pharmaceutical Co Ltd300357.SZ:SAYS CHAIRMAN HU GENGXI RESIGNED DUE TO PERSONAL REASONSource textFurther company coverage:300357.SZ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300357","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146389842","title":"Clinical Trial Application Accepted for Umbilical Cord Mesenchymal Stem Cell Injection by Zhejiang Wolwo Bio-Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1146389842","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146389842?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:02","pubTimestamp":1785232957,"startTime":"0","endTime":"0","summary":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (300357.SZ) has announced that its drug clinical trial application for \"Human Umbilical Cord Mesenchymal Stem Cell Type II Injection\" has been formally...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","PSYK","IBBJ","IBBQ","BMED","MDTX","BK0028","300357"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184044613","title":"How a Missed Mail Delivery Sparked an 11-Year Legal Battle: Wolwo Bio-Pharmaceutical Recoups 13.7 Million Yuan from Former Major Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=1184044613","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184044613?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:21","pubTimestamp":1781778070,"startTime":"0","endTime":"0","summary":"A missing document can carry a hefty price tag, especially in the financial markets, where the cost can reach 13.7 million yuan. Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (ASX: 300357), a company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","300357","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179057936","title":"Clinical Trial Application for Cat Hair Allergen Treatment Receives Regulatory Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1179057936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179057936?lang=en_us&edition=fundamental","pubTime":"2026-06-18 17:12","pubTimestamp":1781773954,"startTime":"0","endTime":"0","summary":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (300357.SZ) has announced that it has received a formal notice of acceptance from the National Medical Products Administration for its clinical trial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0028","300357"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792248558617,"stockEarnings":[{"period":"1week","weight":-0.056},{"period":"1month","weight":-0.0079},{"period":"3month","weight":-0.2088},{"period":"6month","weight":-0.2903},{"period":"1year","weight":-0.3813},{"period":"ytd","weight":-0.3278}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"浙江我武生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35260人(较上一季度减少0.87%)","perCapita":"13766股","listingDate":"2014-01-21","address":"浙江省湖州市德清县武康镇志远北路636号","registeredCapital":"52358万元","survey":"　　浙江我武生物科技股份有限公司的主营业务是过敏性疾病诊断及治疗产品的研发、生产和销售。公司的主要产品是粉尘螨滴剂、黄花蒿花粉变应原舌下滴剂、粉尘螨皮肤点刺诊断试剂盒等系列点刺液产品。","listedPrice":20.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.,300357,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票老虎,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票老虎国际,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.行情,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票行情,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股价,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股市,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票价格,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票交易,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票购买,Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction